Figure 1.

(a) Odds ratios (OR) and 95% confidence intervals (95% CI) for adherence to quality indicators in national guidelines according to educational level and income. (b) Treatment strategies and treatment execution.

Pca: prostate cancer; AS: active surveillance, curative tx: curative treatment (either radical prostatectomy or radiotherapy), GnRH: gonadotropin releasing hormone agonist, RP: radical prostatectomy, RT: radiotherapy; Educational level: low = compulsory school, <10 years; intermediate = upper secondary school, 10–12 years; high = college or university, >12 years; Quartile of disposable income: Q1 lowest – Q4 highest; Risk categories: very low‐risk (T1c, Gleason score (GS) ≤6, Prostate‐specific antigen (PSA) <10 ng/ml, PSA density < 0.15, number of biopsy cores positive for cancer ≤4, cancer extension at biopsy <8mm), low‐risk (T1‐2, PSA <10 ng/mL and GS ≤6), intermediate‐risk (T1‐2, Gleason score 7 and/or PSA 10 to <20 ng/ml), high‐risk (T3 and/or GS 8–10 and/or PSA 20 to <50ng/ml), very high risk (T4, PSA 50 to <200 ng/ml, any N stage, M0), regionally metastatic (T4 and/or N1 and/or PSA 50 to <100 ng/ml in the absence of distant metastases (M0 or Mx), and distant metastases (PSA ⋛100 ng/ml or M1); Advanced prostate cancer includes the risk categories of high‐risk, locally advanced, regionally metastatic, and distant metastases.